Drug Type Small molecule drug  | 
Synonyms-  | 
Action modulators, agonists  | 
Mechanism SCNA modulators(Sodium voltage-gated channel alpha subunits modulators), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhasePhase 3  | 
First Approval Date-  | 
Regulation-  | 
Molecular FormulaC13H23NO7S  | 
InChIKeyOVICLFZZVQVVFT-UHFFFAOYSA-N  | 
CAS Registry51022-70-9  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Asthma | Phase 3 | China   | 20 Nov 2013 | |
| Asthma | Phase 3 | China   | - | 20 Nov 2013 | 
| Pulmonary Disease, Chronic Obstructive | Phase 2 | China   | 09 Jan 2015 | |
| Acute Bronchitis | Phase 1 | China   | 14 Jun 2014 | |
| Asthmatic bronchitis | Phase 1 | China   | 14 Jun 2014 | |
| Bronchial Spasm | Phase 1 | China   | 14 Jun 2014 | |
| Bronchitis, Chronic | Phase 1 | China   | 14 Jun 2014 | 





